neoplasm
• upon necropsy 2 weeks after injection of neoplastically (E1A-plus-Ras-) transformed cells into the peritoneal cavity of female 129/Sv syngeneic mice, homozygous mutant cells yield an increased number of tumor nodules relative to heterozygous mutant cells
|
• in a model of DMBA-induced skin tumorigenesis, homozygotes develop a higher number of benign skin papillomas than heterozygotes, with no significant differences in tumor size or in susceptibility to carcinoma formation over a 16 week observation period
|
homeostasis/metabolism
N |
• homozygotes appear developmentally normal and do not display any defects in wound healing relative to wild-type littermates
|
• in a model of DMBA-induced skin tumorigenesis, homozygotes develop a higher number of benign skin papillomas than heterozygotes, with no significant differences in tumor size or in susceptibility to carcinoma formation over a 16 week observation period
|
cellular
• neoplastically (E1A-plus-Ras-) transformed mutant MEFs display altered actin and proliferative responses to TGFbeta
|
• unlike primary mutant MEFs, neoplastically (E1A-plus-Ras-) transformed mutant MEFs show a significant reduction in the rate of substratum attachment and spreading on fibronectin
|
• primary MEFs derived from homozygous mutant embryos show defective motility on fibronectin, as determined by the rate at which cells move into a cleared section of a confluent monolayer in the presence of the cell division inhibitor mitomycin C
• defective motility on fibronectin is associated with an altered gel mobility of the 1 integrin fibronectin receptor subunit in mutant MEFs
• however, cell adhesion and spreading appear unaffected, and no motility defects are observed during the healing of various types of skin wounds generated in mutant mice
|